SUSD6: A Potential Drug Target and Biomarker for the Treatment of Neurodegenerative Diseases

Target Name: SUSD6

NCBI ID: G9766

SUSD6

SUSD6: A Potential Drug Target and Biomarker for the Treatment of Neurodegenerative Diseases

Sushi domain-containing protein 6 (SUSD6) is a protein that is expressed in various tissues and cells in the human body. SUSD6 has been shown to play a role in the development and progression of several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

The Importance of SUSD6

SUSD6 is a key regulator of the microtubule network, which is a network of filaments that transports proteins and organelles in cells. The microtubule network is involved in many important cellular processes, including cell division, intracellular transport, and the regulation of ion channels. SUSD6 is specifically involved in the regulation of the stability and dynamics of microtubules.

SUSD6 and Neurodegenerative Diseases

Several studies have shown that SUSD6 is involved in the development and progression of several neurodegenerative diseases. For example, studies have shown that SUSD6 is overexpressed in the brains of individuals with Alzheimer's disease, and that this overexpression is associated with the development of neurofibrillary tangles and other hallmark markers of Alzheimer's disease.

In addition, SUSD6 has also been shown to be involved in the development and progression of Parkinson's disease, a neurodegenerative disorder that is characterized by the loss of motor neurons and other motor cells in the brain.

SUSD6 as a Potential Drug Target

The potential use of SUSD6 as a drug target is due to its involvement in the regulation of the microtubule network and its association with the development and progression of neurodegenerative diseases. Drugs that target SUSD6 have the potential to treat neurodegenerative diseases by modulating the activity of this protein.

One approach to targeting SUSD6 is to use small molecules that can modulate the stability and dynamics of SUSD6. These small molecules can either inhibit or enhance the activity of SUSD6, depending on the desired effect. For example, studies have shown that inhibitors of SUSD6 have the potential to treat Alzheimer's disease by reducing the production of neurofibrillary tangles and other hallmark markers of the disease.

Another approach to targeting SUSD6 is to use antibodies that can specifically bind to SUSD6 and prevent it from interacting with its downstream targets. This approach has the potential to treat neurodegenerative diseases by modulating the activity of SUSD6 and its downstream targets.

SUSD6 as a Biomarker

SUSD6 can also be used as a biomarker for the diagnosis and monitoring of neurodegenerative diseases. The levels of SUSD6 in brain tissue can be used to track the progression of the disease and to evaluate the effectiveness of therapeutic interventions.

SUSD6 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and has been used as a biomarker for the diagnosis of this disease. Studies have shown that the levels of SUSD6 in the brains of individuals with Alzheimer's disease are lower than in individuals without the disease. This suggests that SUSD6 may be a potential target for the development of Alzheimer's disease.

In addition, SUSD6 has also been shown to be expressed in the brains of individuals with Parkinson's disease, and has been used as a biomarker for the diagnosis of this disease. Studies have shown that the levels of SUSD6 in the brains of individuals with Parkinson's disease are lower than in individuals without the disease. This suggests that SUSD6 may be a potential target for the development of Parkinson's disease.

Conclusion

Sushi domain-containing protein 6 (SUSD6) is a protein that is involved in the regulation of the microtubule network and its association with the

Protein Name: Sushi Domain Containing 6

Functions: May play a role in growth-suppressive activity and cell death (PubMed:24652652). May be involved in the production of chemokine molecules in umbilical vein endothelial cells (HUVECs) cultured in THP1 monocyte LPS-induced medium (PubMed:20236627). Plays a role in preventing tumor onset (By similarity)

The "SUSD6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUSD6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets